JPMorgan Chase & Co. trimmed its stake in Huntsman Co. (NYSE:HUN – Free Report) by 37.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 237,308 shares of the basic materials company’s stock after selling 144,221 shares during the period. JPMorgan Chase & Co. owned 0.14% of Huntsman worth $5,743,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Matrix Trust Co bought a new position in Huntsman in the 3rd quarter worth $25,000. True Wealth Design LLC purchased a new stake in shares of Huntsman during the third quarter worth about $62,000. Capital Performance Advisors LLP bought a new stake in Huntsman during the 3rd quarter valued at approximately $78,000. Quarry LP lifted its holdings in Huntsman by 64.8% in the 2nd quarter. Quarry LP now owns 3,664 shares of the basic materials company’s stock worth $83,000 after purchasing an additional 1,441 shares in the last quarter. Finally, Rossmore Private Capital bought a new position in Huntsman in the 3rd quarter worth approximately $202,000. 84.81% of the stock is owned by institutional investors.
Huntsman Stock Down 0.0 %
Shares of NYSE:HUN opened at $17.39 on Friday. The company has a 50-day moving average price of $18.66 and a 200 day moving average price of $21.10. The company has a current ratio of 1.47, a quick ratio of 0.83 and a debt-to-equity ratio of 0.45. Huntsman Co. has a 12 month low of $15.95 and a 12 month high of $27.01. The company has a market cap of $3.01 billion, a price-to-earnings ratio of -25.20 and a beta of 0.97.
Huntsman Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 5.75%. The ex-dividend date of this dividend was Friday, December 13th. Huntsman’s payout ratio is -144.93%.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on HUN. Citigroup reduced their price objective on shares of Huntsman from $22.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, December 18th. Mizuho reduced their price target on shares of Huntsman from $23.00 to $21.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th. Morgan Stanley dropped their price objective on shares of Huntsman from $24.00 to $20.00 and set an “equal weight” rating for the company in a report on Monday. UBS Group reduced their target price on Huntsman from $24.00 to $23.00 and set a “neutral” rating on the stock in a report on Tuesday, November 5th. Finally, Wells Fargo & Company dropped their price target on Huntsman from $26.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, Huntsman presently has a consensus rating of “Hold” and an average target price of $23.33.
Get Our Latest Stock Report on HUN
Insider Buying and Selling at Huntsman
In other news, Director Mary C. Beckerle sold 20,201 shares of the firm’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $21.42, for a total value of $432,705.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 6.10% of the company’s stock.
About Huntsman
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Further Reading
- Five stocks we like better than Huntsman
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- How to Use the MarketBeat Dividend Calculator
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Profitably Trade Stocks at 52-Week Highs
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.